All news

(Image: Getty/Zozulya)

Torrent expands recall of losartan products, again

By Ben Hargreaves

Torrent announces that it will recall batches of losartan tablets for the sixth time, after the detection of NMBA exceeding acceptable daily intake levels in latest recall.

(Image: Getty/HS3RUS)

POLL

How invested is pharma in sustainability?

By Ben Hargreaves

As a day of climate strikes unfolds across the world, we ask how far pharma is engaged on the issue, as well as noting recent innovations that suggest companies are looking at what can be done.

(Image: Getty/Rzarek)

Darmerica recalls API lots due to label mix-up

By Vassia Barba

Darmerica recalls two lots of product labeled as quinacrine, a compound used as a sclerosing agent, which were instead found to contain a treatment for malaria.